StageZero Life Sciences Ltd T.SZLS

Grail only 18% Stage 1 and 43% Stage 2

[LithLover]

I recently saw someone on CEO. ca talking about Grail.  I mean come on they are less than 50% detecting cancers up to Stage 2 and yet look at their market value and all the marketing and hype they get.

18% at Stage 1 and 43% for Stage 1 and 2.  Come on.

Stagezero's (detecting cancers at Stage 0) time will come.


https://www.oncodna.com/en/company/activity/news-list/cancer-screening-early-detection-a-methylation-based-ctdna-assay-from-grail-delivered-sensitivity-93-for-stage-iv-cancer-falling-to-43-for-stage-ii-and-18-for-stage-i-disease/

[MarketMoney]

Again it prove's that shareprice is driven by the demand and supply of it's shares....no mater what the fundamental is saying. Look at Gamestop market valuation and what the fundamental is worthed....an insane market cap because of demand for that stock during short squeeze made them a high evaluation market cap.  One day SZLS will do the same, once's investors will want